Home › Research › Treatments
Effects of medication on parotid salivary flow rates in an individual with dementia of the Alzheimer type
Fedele DJ, Jones JA, Volicer L, Herz LR, Oppenheim FG.. Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry, 1993-09-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Data available on the relationship between salivary function and specific drug therapy are sparse. We measured unstimulated and stimulated parotid salivary flow rates associated with the drug therapies. Our ancillary study design is an N = 1 double-blind randomized controlled trial in which the patient undergoes a series of treatment blocks of either placebo or active treatment. The purpose of the parent N of 1 study was to find the "best single drug" treatment for a resistive patient diagnosed with dementia of the Alzheimer type. This study demonstrates that thiothixene was associated with inconsistent effects on parotid flow. Oxazepam had no effect on his parotid function, and diphenhydramine hydrochloride had inconsistent but generally negative effects. The data also show that this individual with dementia of the Alzheimer type had lower baseline unstimulated and stimulated parotid salivary flow rates when compared with mean "normal" values; however, flow rates were above the lowest 10th percentile of "normal" volunteers.
What this study adds
Evidence grade: High
This is a trial. This is a single-patient (N=1) study measuring saliva flow in one person with Alzheimer's disease taking different medications. It found inconsistent effects for thiothixene, no effect for oxazepam, and generally negative effects for diphenhydramine, and says nothing about treating or preventing Alzheimer's itself.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Fedele, D. J., Jones, J. A., Volicer, L., Herz, L. R., & Oppenheim, F. G. (1993). Effects of medication on parotid salivary flow rates in an individual with dementia of the Alzheimer type. Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry. https://doi.org/10.1111/j.1754-4505.1993.tb01499.x
Vancouver
Fedele DJ, Jones JA, Volicer L, Herz LR, Oppenheim FG. Effects of medication on parotid salivary flow rates in an individual with dementia of the Alzheimer type. Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry. 1993. doi:10.1111/j.1754-4505.1993.tb01499.x. PMID: 7716695.
BibTeX
@article{fedele1993-7716695,
author = {Fedele, D. J. and Jones, J. A. and Volicer, L. and Herz, L. R. and Oppenheim, F. G.},
title = {{Effects of medication on parotid salivary flow rates in an individual with dementia of the Alzheimer type}},
journal = {Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry},
year = {1993},
doi = {10.1111/j.1754-4505.1993.tb01499.x},
pmid = {7716695},
url = {https://doi.org/10.1111/j.1754-4505.1993.tb01499.x}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- We measured unstimulated and stimulated parotid salivary flow rates associated with the drug therapies.
- This study demonstrates that thiothixene was associated with inconsistent effects on parotid flow.
- The data also show that this individual with dementia of the Alzheimer type had lower baseline unstimulated and stimulated parotid salivary flow rates when compared with mean "normal" values; however, flow rates were above the lowest 10th percentile of "normal" volunteers.
Why it matters
This is a single-patient (N=1) study measuring saliva flow in one person with Alzheimer's disease taking different medications. It found inconsistent effects for thiothixene, no effect for oxazepam, and generally negative effects for diphenhydramine, and says nothing about treating or preventing Alzheimer's itself.
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Study designrandomized controlled trial
- Evidence strengthHigh
How this study scored 48/100
Published in a peer-reviewed journal, and it is a randomized controlled trial. Scored zero for sample size and effect reported because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry) |
| Journal's citation record | 0 / 4 | Special Care in Dentistry: journal h-index 69 (OpenAlex, 2026-10-29) |
| Study design | 11 / 12 | A randomized controlled trial |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1993 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (pubmed indexes it as a clinical or observational study) |
| Randomized / blinded | 2 / 2 | Randomized and blinded or placebo-controlled (as stated in the record) |
| Times cited | 2 / 7 | Cited 8 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.2 citations a year over 35 year(s) since 1993 |
| Impact for its field and year | 1 / 6 | Cited 0.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Frank G. Oppenheim: h-index 57 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Maryland, Baltimore: institution h-index 970 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 7716695) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 48 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription Unpaywall, Europe PMC and OpenAlex found no free copy of the full text (checked 10 Oct 2026), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Treatments from nearby years
Also tagged “trial”
783 studies in the library carry the topic tag “trial”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.